Coexpression cluster:C290: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Coexpression_clusters
|full_id=C290_Eosinophils_CD14_Basophils_Mast_CD4_CD8_immature
|id=C290
}}") |
No edit summary |
||
Line 1: | Line 1: | ||
{{Coexpression_clusters | {{Coexpression_clusters | ||
|full_id=C290_Eosinophils_CD14_Basophils_Mast_CD4_CD8_immature | |full_id=C290_Eosinophils_CD14_Basophils_Mast_CD4_CD8_immature | ||
|gostat_on_coexpression_clusters=GO:0050789!regulation of biological process!0.0148046825618672!7187;11177;63925;5734;5991;7128;10260;10209;22882$GO:0065007!biological regulation!0.0157128152988876!7187;11177;63925;5734;5991;7128;10260;10209;22882$GO:0050794!regulation of cellular process!0.0247774628528408!63925;5991;7128;22882;7187;10209;10260;11177$GO:0000228!nuclear chromosome!0.0273609379661523!3020;11177$GO:0044424!intracellular part!0.0273609379661523!10730;3020;7187;11177;63925;5991;7128;22882;10260;10209;57132$GO:0003677!DNA binding!0.0273609379661523!63925;3020;5991;7128;22882;10260$GO:0001740!Barr body!0.0273609379661523!3020$GO:0000805!X chromosome!0.0273609379661523!3020$GO:0043231!intracellular membrane-bound organelle!0.0273609379661523!10730;3020;11177;63925;5991;7128;10260;22882;57132$GO:0043227!membrane-bound organelle!0.0273609379661523!10730;3020;11177;63925;5991;7128;10260;22882;57132$GO:0010468!regulation of gene expression!0.0292000980264414!63925;5991;22882;10209;10260;11177$GO:0000803!sex chromosome!0.0292000980264414!3020$GO:0001739!sex chromatin!0.0292000980264414!3020$GO:0031323!regulation of cellular metabolic process!0.0292000980264414!63925;5991;22882;10209;10260;11177$GO:0043124!negative regulation of I-kappaB kinase/NF-kappaB cascade!0.0313510836916462!7128$GO:0019222!regulation of metabolic process!0.0322328454910958!63925;5991;22882;10209;10260;11177$GO:0008270!zinc ion binding!0.0322328454910958!63925;10730;7128;22882;7187;11177$GO:0005634!nucleus!0.0388675441935308!63925;3020;5991;7128;22882;10260;11177$GO:0043283!biopolymer metabolic process!0.0388675441935308!10730;3020;11177;63925;5991;7128;10260;22882$GO:0005720!nuclear heterochromatin!0.0452201402484462!3020$GO:0003676!nucleic acid binding!0.0452201402484462!63925;3020;5991;7128;22882;10209;10260$GO:0016481!negative regulation of transcription!0.0452201402484462!5991;22882$GO:0043229!intracellular organelle!0.0452201402484462!10730;3020;11177;63925;5991;7128;10260;22882;57132$GO:0043226!organelle!0.0452201402484462!10730;3020;11177;63925;5991;7128;10260;22882;57132$GO:0006355!regulation of transcription, DNA-dependent!0.0452201402484462!63925;5991;22882;10260;11177$GO:0046914!transition metal ion binding!0.0452201402484462!63925;10730;7128;22882;7187;11177$GO:0044464!cell part!0.0452201402484462!10730;3020;7187;51249;11177;63925;5734;5991;7128;22882;10260;10209;57132$GO:0045934!negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process!0.0452201402484462!5991;22882$GO:0004957!prostaglandin E receptor activity!0.0452201402484462!5734$GO:0006351!transcription, DNA-dependent!0.0452201402484462!63925;5991;22882;10260;11177$GO:0032774!RNA biosynthetic process!0.0452201402484462!63925;5991;22882;10260;11177$GO:0030278!regulation of ossification!0.0455985375246441!5734$GO:0005622!intracellular!0.0455985375246441!10730;3020;7187;11177;63925;5991;7128;22882;10260;10209;57132$GO:0000792!heterochromatin!0.0459337836461696!3020$GO:0048523!negative regulation of cellular process!0.0459337836461696!5991;7128;22882$GO:0004955!prostaglandin receptor activity!0.0459337836461696!5734$GO:0000790!nuclear chromatin!0.0459337836461696!3020$GO:0045449!regulation of transcription!0.0459337836461696!63925;5991;22882;10260;11177$GO:0031324!negative regulation of cellular metabolic process!0.0459337836461696!5991;22882$GO:0046850!regulation of bone remodeling!0.0459337836461696!5734$GO:0048519!negative regulation of biological process!0.0459337836461696!5991;7128;22882$GO:0019219!regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process!0.0459337836461696!63925;5991;22882;10260;11177$GO:0004953!icosanoid receptor activity!0.0459337836461696!5734$GO:0003705!RNA polymerase II transcription factor activity, enhancer binding!0.0459337836461696!5991$GO:0004954!prostanoid receptor activity!0.0459337836461696!5734$GO:0006350!transcription!0.0459337836461696!63925;5991;22882;10260;11177$GO:0010467!gene expression!0.0459337836461696!63925;5991;22882;10209;10260;11177$GO:0006402!mRNA catabolic process!0.0471613307300842!22882$GO:0009892!negative regulation of metabolic process!0.0488373563300737!5991;22882 | |||
|id=C290 | |id=C290 | ||
}} | }} |
Revision as of 17:38, 18 May 2012
Full id: C290_Eosinophils_CD14_Basophils_Mast_CD4_CD8_immature
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0050789 | regulation of biological process | 0.0148046825618672 |
GO:0065007 | biological regulation | 0.0157128152988876 |
GO:0050794 | regulation of cellular process | 0.0247774628528408 |
GO:0000228 | nuclear chromosome | 0.0273609379661523 |
GO:0044424 | intracellular part | 0.0273609379661523 |
GO:0003677 | DNA binding | 0.0273609379661523 |
GO:0001740 | Barr body | 0.0273609379661523 |
GO:0000805 | X chromosome | 0.0273609379661523 |
GO:0043231 | intracellular membrane-bound organelle | 0.0273609379661523 |
GO:0043227 | membrane-bound organelle | 0.0273609379661523 |
GO:0010468 | regulation of gene expression | 0.0292000980264414 |
GO:0000803 | sex chromosome | 0.0292000980264414 |
GO:0001739 | sex chromatin | 0.0292000980264414 |
GO:0031323 | regulation of cellular metabolic process | 0.0292000980264414 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 0.0313510836916462 |
GO:0019222 | regulation of metabolic process | 0.0322328454910958 |
GO:0008270 | zinc ion binding | 0.0322328454910958 |
GO:0005634 | nucleus | 0.0388675441935308 |
GO:0043283 | biopolymer metabolic process | 0.0388675441935308 |
GO:0005720 | nuclear heterochromatin | 0.0452201402484462 |
GO:0003676 | nucleic acid binding | 0.0452201402484462 |
GO:0016481 | negative regulation of transcription | 0.0452201402484462 |
GO:0043229 | intracellular organelle | 0.0452201402484462 |
GO:0043226 | organelle | 0.0452201402484462 |
GO:0006355 | regulation of transcription, DNA-dependent | 0.0452201402484462 |
GO:0046914 | transition metal ion binding | 0.0452201402484462 |
GO:0044464 | cell part | 0.0452201402484462 |
GO:0045934 | negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0452201402484462 |
GO:0004957 | prostaglandin E receptor activity | 0.0452201402484462 |
GO:0006351 | transcription, DNA-dependent | 0.0452201402484462 |
GO:0032774 | RNA biosynthetic process | 0.0452201402484462 |
GO:0030278 | regulation of ossification | 0.0455985375246441 |
GO:0005622 | intracellular | 0.0455985375246441 |
GO:0000792 | heterochromatin | 0.0459337836461696 |
GO:0048523 | negative regulation of cellular process | 0.0459337836461696 |
GO:0004955 | prostaglandin receptor activity | 0.0459337836461696 |
GO:0000790 | nuclear chromatin | 0.0459337836461696 |
GO:0045449 | regulation of transcription | 0.0459337836461696 |
GO:0031324 | negative regulation of cellular metabolic process | 0.0459337836461696 |
GO:0046850 | regulation of bone remodeling | 0.0459337836461696 |
GO:0048519 | negative regulation of biological process | 0.0459337836461696 |
GO:0019219 | regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0459337836461696 |
GO:0004953 | icosanoid receptor activity | 0.0459337836461696 |
GO:0003705 | RNA polymerase II transcription factor activity, enhancer binding | 0.0459337836461696 |
GO:0004954 | prostanoid receptor activity | 0.0459337836461696 |
GO:0006350 | transcription | 0.0459337836461696 |
GO:0010467 | gene expression | 0.0459337836461696 |
GO:0006402 | mRNA catabolic process | 0.0471613307300842 |
GO:0009892 | negative regulation of metabolic process | 0.0488373563300737 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.